5am Opportunities I, L.p. - Net Worth and Insider Trading

5am Opportunities I, L.p. Net Worth

The estimated net worth of 5am Opportunities I, L.p. is at least $3 Million dollars as of 2024-12-27. 5am Opportunities I, L.p. is the 10% Owner of Rallybio Corp and owns about 3,730,724 shares of Rallybio Corp (RLYB) stock worth over $3 Million. Details can be seen in 5am Opportunities I, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that 5am Opportunities I, L.p. has not made any transactions after 2022-06-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of 5am Opportunities I, L.p.

To

5am Opportunities I, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, 5am Opportunities I, L.p. owns 12 companies in total, including Aprea Therapeutics Inc (APRE) , Akouos Inc (AKUS) , and scPharmaceuticals Inc (SCPH) among others .

Click here to see the complete history of 5am Opportunities I, L.p.’s form 4 insider trades.

Insider Ownership Summary of 5am Opportunities I, L.p.

Ticker Comapny Transaction Date Type of Owner
APRE Aprea Therapeutics Inc 2019-10-07 10 percent owner
AKUS Akouos Inc 2020-06-25 10 percent owner
SCPH scPharmaceuticals Inc 2020-05-26 other: See Remarks
LIMIT LIMIT 2019-10-29 10 percent owner
LIMIT LIMIT 2021-04-27 10 percent owner
LIMIT LIMIT 2020-11-11 10 percent owner & Former 10% holder
LIMIT LIMIT 2021-10-28 10 percent owner
LIMIT LIMIT 2022-06-03 10 percent owner
LIMIT LIMIT 2021-02-04 10 percent owner
LIMIT LIMIT 2021-12-03 10 percent owner
LIMIT LIMIT 2022-01-06 10 percent owner
LIMIT LIMIT 2023-02-23 10 percent owner

5am Opportunities I, L.p. Latest Holdings Summary

5am Opportunities I, L.p. currently owns a total of 1 stock. 5am Opportunities I, L.p. owns 3,730,724 shares of Rallybio Corp (RLYB) as of June 3, 2022, with a value of $3 Million.

Latest Holdings of 5am Opportunities I, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
RLYB Rallybio Corp 2022-06-03 3,730,724 0.92 3,432,266

Holding Weightings of 5am Opportunities I, L.p.


5am Opportunities I, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, 5am Opportunities I, L.p. has made a total of 3 transactions in Rallybio Corp (RLYB) over the past 5 years, including 1 buys and 2 sells. The most-recent trade in Rallybio Corp is the sale of 150,000 shares on June 3, 2022, which brought 5am Opportunities I, L.p. around $2 Million.

Insider Trading History of 5am Opportunities I, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

5am Opportunities I, L.p. Trading Performance

GuruFocus tracks the stock performance after each of 5am Opportunities I, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by 5am Opportunities I, L.p. is 5.56%. GuruFocus also compares 5am Opportunities I, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by 5am Opportunities I, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how 5am Opportunities I, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of 5am Opportunities I, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -27.56 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -30.97 LIMIT LIMIT LIMIT LIMIT LIMIT

5am Opportunities I, L.p. Ownership Network

Ownership Network List of 5am Opportunities I, L.p.

No Data

Ownership Network Relation of 5am Opportunities I, L.p.

Insider Network Chart

5am Opportunities I, L.p. Owned Company Details

What does Aprea Therapeutics Inc do?

Who are the key executives at Aprea Therapeutics Inc?

5am Opportunities I, L.p. is the 10 percent owner of Aprea Therapeutics Inc. Other key executives at Aprea Therapeutics Inc include President & CEO Oren Gilad , SrVP/CFO/Prin. Fin &Acctg. Off John P. Hamill , and director & President & CEO Christian S Schade .

Aprea Therapeutics Inc (APRE) Insider Trades Summary

Over the past 18 months, 5am Opportunities I, L.p. made no insider transaction in Aprea Therapeutics Inc (APRE). Other recent insider transactions involving Aprea Therapeutics Inc (APRE) include a net purchase of 3,900 shares made by Oren Gilad , a net purchase of 23,728 shares made by Marc Duey , and a net purchase of 1,510 shares made by John P. Hamill .

In summary, during the past 3 months, insiders sold 6,462 shares of Aprea Therapeutics Inc (APRE) in total and bought 42,590 shares, with a net purchase of 36,128 shares. During the past 18 months, 6,462 shares of Aprea Therapeutics Inc (APRE) were sold and 59,320 shares were bought by its insiders, resulting in a net purchase of 52,858 shares.

Aprea Therapeutics Inc (APRE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aprea Therapeutics Inc Insider Transactions

No Available Data

5am Opportunities I, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for 5am Opportunities I, L.p.. You might contact 5am Opportunities I, L.p. via mailing address: 501 Second Street, Suite 350, San Francisco Ca 94107.

Discussions on 5am Opportunities I, L.p.

No discussions yet.